JATT Acquisition Corp. (NYSE: JATT)

JATT Acquisition Corp. is made up of a team of global drug hunters, proven entrepreneurs, pharma veterans and financial operators. With several decades of combined experience and successful multi-billion dollar deals, we have honed our formula to unlock future value powered by deep sector and capital markets knowledge

Team

Dr. Someit Sidhu

Founder, CEO & Director Co-Founder and CEO of Izana Bioscience & Akaza, Co-Founder of Pathios Therapeutics

Verender S. Badial

Co-investor, Former MD in ECM at Société Générale and ABN AMRO Rothschild, Founder of Cryfield Investments

Tauhid Ali ,PhD

Founder, CEO & Director Co-Founder and CEO of Izana Bioscience & Akaza, Co-Founder of Pathios Therapeutics

Graeme Sloan

Founder, CEO & Director Co-Founder and CEO of Izana Bioscience & Akaza, Co-Founder of Pathios Therapeutics

Arnout Ploos van Amstel

Co-Founder of MoonLake Immunotherapeutics and Former Head of Global Business Unit Immunology, Hepatalogy and Dermatology at Novartis

Javier Cote‐Sierra, PhD

Co-Founder & CSO of Allianthera Biopharma and Former Head of Inflammation & Immunology External Innovation at Sanofi Genzyme

Yuan-Hua Ding, PhD Advisor

Co-Founder & CEO of Allianthera Biopharma and Co-CEO at the BayRay Innovation Center, former Head of Pfizer Asia Discovery Labs

Investor Relation

Price updates

SEC Filing

News

Zura Bio Closed Merger with JATT
Initial Public Offering
JATT’s Proposed Business Combination With Zura Bio Declared Effective by SEC
Deal With ZuraBio
Contact Us

info@jattacquisition.com